Welcome to Chipbio

Tel:028-85968418
Industry news

Industry news CFDA announced that after the review

CFDA announced that after the review 2017-07-23
In May 16, 2017, CFDA announced that after the review, approval of the country's first "interventional biological heart valve products" registration. The announcement wrote, the product without the automatic positioning of the implantation site fast cardiac pacing case for aortic insufficiency patients belonging to the domestic initiative, the listing will suffer from aortic stenosis and aortic valve insufficiency in patients with significant clinical benefit.